Answers are grounded in this paper and cite their sources.
The implementation of next generation sequencing techniques, such as whole genome sequencing (WGS), in tuberculosis (TB) research has enabled timely, cost-effective, and comprehensive insights into the genetic repertoire of the human pathogens of the Mycobacterium tuberculosis complex (MTBC). WGS data allow for detailed epidemiological analysis based on genomic distance of the MTBC strains under investigation, e.g. for tracing outbreaks; it can accelerate diagnostics by predicting drug resistance from a mutation catalogue (figure 1). Indeed, specific mutations even permit predictions on the possible clinical treatment course and outcome.
No takes yet. Share an insight, caveat, or question.
Gröschel et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: